First-ever clinical guidelines for injectable opioid treatments
CHÉOS Scientist Dr. Eugenia Oviedo-Joekes is a co-author on the first-ever clinical guidelines for use of injectable opioid agonist treatment for opioid use disorder.
Read MoreCHÉOS Scientist Dr. Eugenia Oviedo-Joekes is a co-author on the first-ever clinical guidelines for use of injectable opioid agonist treatment for opioid use disorder.
Read MoreCHÉOS Scientists Drs. Skye Barbic and Frank Scheuermeyer are teaming up to improve the integration between emergency departments and mental health services for youth and young adults.
Read MoreThe latest CHÉOS-related news for the weeks of September 1 & 8.
Read MoreWork published by CHÉOS emergency medicine Scientists points to the need for standardizing the way emergency departments treat atrial fibrillation
Read MoreRead about the Scientists and research that appeared in the media this summer.
Read MoreThe latest CHÉOS-related news for the weeks of August 18 & 25.
Read MoreThe 32nd edition summarizes some of the latest research from CHÉOS Scientists, including cognitive decline after surgery, financial incentives in the ED, and treatment decision aids in MS patients.
Read MoreThe latest CHÉOS-related news for the weeks of August 4 & 11.
Read MoreDana Nohynek, Director of Regulatory Affairs and Quality Assurance, provides an overview of how and why to manage risk in clinical trials.
Read MoreCHÉOS Scientists publish first longitudinal study evaluating the relationship between anti-inflammatory drugs, osteoarthritis, and cardiovascular disease
Read More